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ITV coverage was then evaluated by comparing the volume 
covered by the prescription isodose on full bladder CT-
planning and CT-control. 
Patients were asked to have full bladder but they did not 
follow specific recommendation for rectum. 
We investigated the correlation of 3D vector and loss of 
dosimetric coverage with bladder volume, rectal volume, 
maximum rectal diameter and AP rectal diameter at tip of 
coccyx level. 
Results: The ITV displacements turned out to be (mean ± SD) 
0.17 ± 0.12cm (range 0.01-0.50) in Left-Right, 0.41 ± 0.31cm 
(0.03-1.26) in anteroposterior and 0.35 ± 0.28cm (0.00-0.93) 
in craniocaudal direction. Mean 3D vector was 0.64 ± 0.32cm 
(0.09-1.30). 
All patients with 3D vector<0.7 cm (59.3%) showed a loss of 
coverage less than 10%. The rest of patients had a 3D 
vector>0.7 cm, but only 15% (4/27) had a loss of coverage 
higher than 10% (range 16.4-20.2%). 
We found a correlation between the 3D vector and the loss of 
coverage (Pearson correlation 0,51; p=0,007). 
We did not find any significant correlation of different rectal 
and bladder parameters with the 3D vector and loss of 
dosimetric coverage.  
Conclusions: Although vaginal movement was observed for 
the patients, only few of them showed a significant loss of 
coverage. We were unable to find that rectum and bladder 
filling had significant effect on the ITV displacement or loss 
of dosimetric coverage. Vaginal ITV is a good procedure to 
ensure an acceptable dosimetric coverage. 
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Purpose/Objective: Aim of this study was to assess the role 
of whole-body 18F-fluorodeoxyglucose Positron Emission 
Tomography (18F-FDG PET) and Magnetic Resonance Imaging 
(MRI) in the management of cervical cancer. 
Materials and Methods: In pretreatment staging, 93 patients 
with histological diagnosis of cervical cancer, underwent 18F-
FDG PET in addition to routine protocol including 
International Federation of Obstetrics and Gynecology (FIGO) 
staging and MRI.  
Results: In all patients both 18F-FDG PET and MRI detected 
the primary tumor. 
In 67 patients (72%) the result of 18F-FDG PET and MRI was the 
same, but in 29 patients (31.2%) the result was different: 18F-
FDG PET detected pelvic nodal metastases not seen by MRI in 
11 cases (11.8%) and MRI detected pelvic nodal metastases 
not seen by 18F-FDG PET in 15 cases (16.1%). In 3 cases (3.2%) 
both exams was positive, but 18F-FDG PET showed a higher 
number of pelvic nodal metastases than MRI. Furthermore in 
20 cases (21.5%) 18F-FDG PET showed para-aortic nodal 
metastases. 
Conclusions: Integrating two imaging techniques allowed the 
identification of a higher number of pelvic nodal metastases, 
achieving a better initial staging and subsequent appropriate 
treatment. Finally, whole-body 18F-FDG PET was useful for 
staging extrapelvic nodal metastases.  
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Purpose/Objective: Application of conformal radiotherapy 
(CRT) with different regimes of dose fractionation in patients 
with locally advanced cervical cancer is a promising 
technique to increase the treatment effectiveness. The 
purpose of the presented work was to evaluate the efficacy 
and toxicity of the regime of accelerated fractionation during 
CRT and in vivo cytogenetic monitoring in patients with 
locally advanced cervical cancer. 
Materials and Methods: A course of combined radiotherapy 
for 37 patients with locally advanced cervical cancer treated 
on the phase I with CRT by Clinac 2100/CD linear accelerator 
with 6 MeV bremsstrahlung radiation in two regimes: 
fractionated regime of 1,3 Gy per fraction delivered twice 
daily with 4 h interval to the total focal dose of 39 Gy for the 
tumor node and 44 Gy for the pelvic lymph nodes ( group I, 
n=16) vs. standard fractionation regime of single 2,0 Gy dose 
exposure to the total focal dose of 45-46 Gy on the pelvic 
area (group II, control, n=21). In phase II of the radiotherapy 
course intracavitary brachytherapy with high-activity ??60 
source («Gyne Source») was used in the treatment of all 
patients in the regime of single 5 Gy dose exposure of the p. 
A 2 given twice daily to the total dose of 35-40 Gy/ 7-8 
fractions. Peripheral blood lymphocytes (PBL) of the cancer 
patients were the objects of cytogenetic analysis 
(chromosomal aberrations). Blood sampling in patients of 
group I was performed three times: before the CRT, and 
during the first treatment exposure; in patients of group II - 
twice: before the CRT and 24 h after first fraction.  
Results: In group I complete regression (CR) of tumors was 
registered in 21,4%, partial tumor regression (PR) - in 50,0%, 
stabilization process - in 28,6% of patients; in group II 
(control) it was 18,3%, 42,1% and 39,6% of patients with 
locally advanced cervical cancer, respectively. 
Analysis of the in vivo release of radiation markers in PBL of 
CC patients showed that accumulation rate of dicentric and 
ring chromosomes after the first treatment at the regime of 
dose accelerated fractionation (group I) was significantly 
lower in comparison with standard fractionation schedule 
(group II): 1,01 ± 0,05 per 100 metaphases after the first 
fraction of 1,3 Gy, 1,9 ± 0,15 per 100 metaphases after total 
daily dose of 2,6 Gy and 2,6 ± 0,1 per 100 metaphases 
analyzed, respectively.  
Conclusions: Analysis of the direct efficacy and toxicity of 
the treatment of the patients with locally advanced cervical 
